Which Semaglutide effects can help or cause trouble?

What do people gain, and what can be hard to bear?

Users commonly describe weight falling after hunger eases, with stomach trouble their chief complaint. People with diabetes also describe better sugar readings while they use the medicine. You may recognize your own experience among the good and bad accounts. Personal accounts haven't had the checks that studies use when comparing treatment groups.

Studies found benefits and harms by following people and checking what changed during treatment. Researchers could compare groups rather than depend only on what someone later remembered. A nausea report describes one person’s experience without proving the cause, which means your doctor needs to weigh the account against the problems found when studies actually compared treatment groups.

Patients often report strange burps, nausea or changed bowel habits when treatment starts. Those problems can grow worse just after the amount of medicine goes up. Other concerns include pregnancy safety and tumors in the thyroid, the gland in your neck. The findings below say whether the trouble was measured in people or only seen in animals.

What did users say changed in their daily lives?

Patients and research users supplied these accounts of semaglutide use. Users described these experiences, including during research use; these accounts weren't tested against another group in a controlled study. You can recognize a complaint without assuming that semaglutide caused every change reported. Someone else's experience doesn't settle what will happen to your meals, weight or health.

What felt helpful to the people reporting?

• Food took up less of their attention, a frequent report. Users describe going through the day with fewer repeated thoughts about what to eat next. For some, that relief began during the first week or two of treatment. People reported portions between a third and a half of their former size because fullness came sooner. Many valued freedom from constant thoughts of food as much as lower weight.
• Sweets and fatty meals lost their appeal, a frequent report. Some said they stopped craving sugar, or lost interest in sweets altogether. Fried dishes or greasy food could seem unpleasant when those foods had previously been tempting. People sometimes found fruit, vegetables and lighter dishes easier to choose without forcing themselves.
• The scale kept falling for months, a frequent report. Users often described large losses of weight that continued for several months during treatment. Early changes sometimes came faster, with slower progress on the scale later on. According to those people, eating smaller meals after hunger eased explained much of the loss.
• Sugar readings improved, a common report. People treating type 2 diabetes described lower readings both at home and during blood tests. Some said morning sugar and the test of their longer-term average reached normal levels. Those results were reported by users, so they can't forecast the change in your sugar.
• Alcohol seemed less tempting, an occasional report. A few noticed a change in the wish to drink alongside their reduced hunger. Some said the urge to drink went away, with less need to resist it. That report doesn't prove semaglutide changed alcohol use.

What made daily life harder for those users?

• Feeling sick or vomiting, a frequent report. Nausea appears in roughly a third of the reviews, with vomiting in some accounts too. Symptoms were often worst at the start or just after the amount of medicine increased. Users described a week or two of nausea before feeling better. Rich food or too large a meal could bring symptoms back, while smaller meals and enough water helped many bear the discomfort.
• Burps with a rotten-egg smell, a common report. Users described a sulfur smell along with bloating or fullness that stayed with them. Many noticed worse burps after the amount of semaglutide rose during treatment. Burping appears often in these accounts, though printed side-effect lists give the complaint less attention.
• Hard stools or loose stools, a common report. Constipation meant hard stools and fewer bowel movements; diarrhea meant frequent loose stools. Some users experienced both problems at different times during treatment. Loose stools were sometimes noticed soon after a shot or after eating rich dishes.
• Burning from heartburn or indigestion, an occasional report. Some people described acid coming back up as well as bloating and burping. They often noticed the trouble when the amount of medicine had recently risen. Their reports don't explain the cause of heartburn that you might develop.
• Less energy soon after starting, a common report. Tiredness could appear during the first day or two following a semaglutide shot. Some users felt low energy for several weeks before they began feeling more like themselves. Another person's report can't tell you why tiredness has appeared or how long you'll feel it.
• Food tasted or smelled unpleasant, an occasional report. Some people noticed a metallic taste, or strong smells that made eating less appealing. Meat and fatty dishes could be especially unpleasant, with a few users comparing the feeling to morning sickness. Others needed reminders to eat because their appetite had become so much smaller.
• Thinner hair and a face that looked hollow, a less frequent report. A few people described shedding hair and a more hollow face after several months of treatment. Those users often blamed fast weight loss, but a personal account can't establish that cause. Hair shedding was mostly described as passing, with growth returning after the spell of loss.
• Headaches and lightheadedness, an occasional report. Some described these symptoms within days of changing the amount of medicine taken. Users sometimes connected headaches or dizziness with too little food or water while hunger was low. Many felt better after drinking enough water, though that doesn't prove the cause of your symptoms.
• Skin felt sore or itchy where the shot was given, a less frequent report. People described redness, itching, tenderness or a little bump around the needle site. People generally said the skin trouble was slight and went away fairly quickly. A lasting or different skin change in you can't be explained by these accounts alone.

What do studies say about Semaglutide side effects?

The clearest common harms in human trials were symptoms affecting the stomach or bowels. Studies also looked for rarer problems, but haven't settled every possible long-term risk. Your age, illnesses and other medicines affect how your doctor weighs the findings. The warnings below distinguish problems measured in people from concerns that remain uncertain.

Why did some patients stop when stomach trouble became hard to bear? The main trial complaints were vomiting and nausea, or bowel problems such as constipation and diarrhea. Most symptoms passed and were mild, often appearing while the amount of medicine increased. About one patient in three had nausea, according to a review of safety findings ^[5][16]. Food passes out of the stomach less quickly, helping explain the unsettled feeling ^[9].

What does the warning about the thyroid mean for your family? In rats and mice, very large amounts of GLP-1 medicines caused tumors in some thyroid cells. Studies haven't established that thyroid cancer occurs more often in people because of semaglutide ^[17][5]. The instructions rule out use with a personal or family history of medullary thyroid cancer, a cancer in certain cells of the neck gland. Multiple endocrine neoplasia type 2 is an inherited illness that causes gland tumors and also rules out use.

What is the pancreas, and why can swelling there be serious? The pancreas is a gland behind your stomach that makes insulin and helps digest food. Sudden inflammation there can cause severe, lasting upper-belly pain, sometimes reaching the back. Suspected swelling generally leads the doctor to stop treatment; the warning applies to the GLP-1 drug group. Too few pancreatic cancer cases occurred to settle that cancer risk in the review ^[5].

What did the gallstone findings show? Gallstones were more common on semaglutide than on placebo, treatment without active medicine ^[5]. Researchers largely link the increase to how quickly weight fell and how much was lost. The increase was measured in trials and reported as use of the medicine became wider. Those findings don't prove that semaglutide directly damages the gallbladder, which stores fluid used to digest fats.

Why might diabetes already affecting your eyes need closer checks? SUSTAIN-6 found more eye problems, mainly among patients with damage from diabetes before treatment began ^[2]. Trouble was concentrated among patients whose blood sugar fell quickly during treatment. A rapid fall in sugar seems likelier to explain the worsening than direct damage from semaglutide. Your doctor may need closer eye checks when your sugar readings come down quickly ^[5].

Could losing muscle matter more as you get older? Part of a study found that people lost some muscle, in addition to losing fat ^[18]. Muscle helps you rise from a chair, move about and keep your strength. Researchers are therefore interested in protein intake and exercise that builds muscle during weight loss. Muscle loss was measured; later weakness remains a concern rather than a proven result.

How lasting were the gains when treatment ended? In follow-up to STEP 1, much of the weight lost returned during the year after people stopped. Sugar readings and measures of heart health drifted toward their starting levels too. In STEP 4, weight rose again after patients changed to placebo ^[19][20]. Those findings suggest the benefits may need continued treatment rather than a brief course.

Does hair shedding prove that the drug damages hair? Safety reports raised concern during use of semaglutide or tirzepatide, another medicine for weight and diabetes ^[21]. These reports don't mean people were taking both drugs together during treatment. Another study linked widespread hair shedding with losing larger amounts of weight quickly ^[22]. Rapid weight loss seems the likelier cause, and hair usually returns, but the reports can't settle each case.

Why is there a delay before a planned pregnancy? The instructions advise against use during pregnancy because the medicine may cause harm. About half leaves the body within a week, with most gone in about five weeks. Guidance allows roughly two months after stopping before planning to become pregnant ^[23]. That delay gives medicine still present in blood time to leave the body.

What did the tablet's empty-stomach instructions mean? An added substance helps swallowed semaglutide enter blood, though most still never reaches blood. The recorded instructions specified an empty stomach and no more than about half a cup of plain water. Food, other drinks and other tablets had to wait at least half an hour ^[24][23]. Taking the tablet differently can reduce how much reaches blood, which may weaken its effect.

Which other medicines may need extra checks? A review checked other tablets and found few meaningful problems from food staying in the stomach longer. The caution concerns drugs where a small change in the amount reaching blood could cause harm. Your doctor may check blood levels or the drug's effect, especially while semaglutide doses rise ^[25]. Examples include warfarin, a blood thinner, and digoxin, a heart medicine; the overall risk of drugs affecting each other was low.

When did studies widen the uses of this medicine?

Semaglutide's uses grew as researchers measured more than changes in blood sugar. Its lasting effect comes from changes that resist breakdown and help it attach to a blood protein. That protein holds semaglutide in blood longer than GLP-1, the gut's short-lived fullness hormone. A longer stay helps explain why weekly shots could be tested for lasting weight and health changes.

The first type 2 diabetes approval came in 2017, with tablets around 2019-2020 and weight care in 2021 ^[23]. SELECT reported heart findings in 2023; FLOW reported kidney findings in 2024. Uses aimed at protecting the kidneys and heart followed, with a liver use added in 2025 ^[3][6]. That use concerns MASH, where fat inflames the liver, with moderate to advanced scarring without cirrhosis, severe scarring that changes the liver’s structure.

A shortage from roughly 2022 until early 2025 allowed pharmacies to prepare their own semaglutide. Those permissions narrowed after officials said enough supply was available in early 2025 ^[2]. Results for the manufactured drug don't establish the safety of each pharmacy's preparation. You can read about that difference on the dosage page before assuming the evidence is the same.